"The US Food and Drug Administration (FDA) has given the go-ahead for the controversial transplant of embryonic stem cells into the eyes of patients with Stargardt's macular degeneration, where the light-sensitive retina cells at the back of eye are destroyed.
The announcement follows the first injection of embryonic stem cells into a patient in the US who is partially paralysed as a result of a spinal cord injury. Last October, a US biotechnology company, Geron, announced the start of the first clinical trial of embryonic stem cells with the hope of repairing damaged nerves."
Sunday, November 21, 2010
Stem cells could help blind patients to see within six weeks - Science, News - The Independent
Stem cells could help blind patients to see within six weeks - Science, News - The Independent:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment